LexaGene is a biotechnology company developing automated and sensitive instrumentation for rapid pathogen detection.
Our breakthrough technology will transform how pathogens are detected and deliver results in about an hour.
30 November 2017 – LexaGene completes prototype assembly for soon-to-be first fully automated, open-access pathogen detection system.
Innovation in the Making
Imagine a new way of testing on site for multiple pathogens that uses customized genetic screening, doesn’t requite a skilled technician,
and returns results in just one hour. See what’s new with LexaGene and how we are changing the future of pathogen detection.
LexaGene on Fox Biz TV
LexaGene was featured on an episode of Innovations with Ed Begley Jr. which aired on Fox Business Network Saturday 26 August and 9 September @ 5pm ET. Learn more about LexaGene by watching the segment.
We are commercializing the first ‘open-access’ instrument for pathogen detection, allowing users an on-site instrument to target any gene sequence of interest, and return results in about an hour.
Special note from CEO
Today is the day we can proudly say that we have met our initial goal…as the instrument is finally assembled! For the past year…